- Home
- MNSB vs BDTX Comparison
MNSB vs BDTX Comparison
Compare MNSB & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNSB
- BDTX
- Stock Information
- Founded
- MNSB 2003
- BDTX 2014
- Country
- MNSB United States
- BDTX United States
- Employees
- MNSB N/A
- BDTX 54
- Industry
- MNSB Major Banks
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MNSB Finance
- BDTX Health Care
- Exchange
- MNSB Nasdaq
- BDTX Nasdaq
- Market Cap
- MNSB 137.1M
- BDTX 126.8M
- IPO Year
- MNSB N/A
- BDTX 2020
- Fundamental
- Price
- MNSB $16.80
- BDTX $2.24
- Analyst Decision
- MNSB
- BDTX Strong Buy
- Analyst Count
- MNSB 0
- BDTX 4
- Target Price
- MNSB N/A
- BDTX $15.50
- AVG Volume (30 Days)
- MNSB 7.3K
- BDTX 1.2M
- Earning Date
- MNSB 01-21-2025
- BDTX 03-11-2025
- Dividend Yield
- MNSB 2.34%
- BDTX N/A
- EPS Growth
- MNSB N/A
- BDTX N/A
- EPS
- MNSB 1.21
- BDTX N/A
- Revenue
- MNSB $62,730,000.00
- BDTX N/A
- Revenue This Year
- MNSB N/A
- BDTX N/A
- Revenue Next Year
- MNSB $5.16
- BDTX N/A
- P/E Ratio
- MNSB $14.17
- BDTX N/A
- Revenue Growth
- MNSB N/A
- BDTX N/A
- 52 Week Low
- MNSB $14.97
- BDTX $1.91
- 52 Week High
- MNSB $22.40
- BDTX $7.66
- Technical
- Relative Strength Index (RSI)
- MNSB 37.20
- BDTX 48.23
- Support Level
- MNSB $16.52
- BDTX $2.02
- Resistance Level
- MNSB $16.91
- BDTX $2.33
- Average True Range (ATR)
- MNSB 0.41
- BDTX 0.17
- MACD
- MNSB -0.08
- BDTX 0.03
- Stochastic Oscillator
- MNSB 17.11
- BDTX 43.42
About MNSB MainStreet Bancshares Inc.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.